Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Roche Innovation Center Copenhagen A/S currently manages 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 2 distinct examiners but are concentrated within 1 distinct art unit. Jenna L. Persons is identified as the busiest examiner, currently handling 1 pending office action.
The use of 1 distinct art unit for the pending office actions indicates a localized prosecution strategy within a specific technical field. Although multiple examiners are involved, the shared art unit suggests a consistent set of examination guidelines. With Jenna L. Persons managing a pending office action, the portfolio's progress is split between the assigned examiners.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PERSONS, JENNA L | 1 | 50.8% | +61.7% |
| VYAS, KEYUR ANILKUMAR | 1 | 49.4% | +60.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17264790 | OLIGONUCLEOTIDES COMPRISING A PHOSPHOROTRITHIOATE INTERNUCLEOSIDE LINKAGE | VYAS, KEYUR ANILKUMAR | 28d overdue |
| 17594154 | ANGPTL2 ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF | PERSONS, JENNA L | 34d |
| Art Unit | Apps |
|---|---|
| 1637 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17594154 | ANGPTL2 ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF | PERSONS, JENNA L | 1637 | §103 | Non-Final OA | 34d | Pending | Oct 04, 2021 |
| 17264790 | OLIGONUCLEOTIDES COMPRISING A PHOSPHOROTRITHIOATE INTERNUCLEOSIDE LINKAGE | VYAS, KEYUR ANILKUMAR | 1637 | §103 | Non-Final OA | 28d overdue | Pending | Jan 29, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial